As serum CEA, CA125, and CA199 levels could reflect tumor invasiveness [31], peritoneal free tumor cells in the ascites [32], and proliferative activity of tumor cells in ascites or primary tumor [33], respectively, the reduction of these TM could provide direct evidence that CRS + HIPEC is effective to control PC. The gene discussed is CEACAM5; the disease is pachyonychia congenita.